CPMD Cannapharmarx, Inc.

Fundamentals / CIK 0001081938 / USD

Cannapharmarx, Inc. reported $1.18M in revenue and a net loss of $9.20M for the trailing twelve months ended September 30, 2026 (down 79.0% year over year), with a -130.7% gross margin and a -210.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CPMD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$5.79M$2.90M$0-$19.44MFY 2016 Revenue: $0FY 2016 Net Income: -$1.00M2016FY 2017 Revenue: $0FY 2017 Net Income: -$6.6K2017FY 2018 Revenue: $0FY 2018 Net Income: -$3.09M2018FY 2019 Revenue: $0FY 2019 Net Income: -$20.45M2019FY 2020 Revenue: $0FY 2020 Net Income: -$19.89M2020FY 2021 Revenue: $0FY 2021 Net Income: -$8.83M2021FY 2022 Revenue: $0FY 2022 Net Income: -$8.53M2022FY 2023 Revenue: $0FY 2023 Net Income: $3.69M2023FY 2024 Revenue: $820KFY 2024 Net Income: -$9.91M2024FY 2025 Revenue: $1.36MFY 2025 Net Income: -$11.13M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.36M $820K $0 $0 $0 $0 $0 $0 $0 $0
Cost of Revenue $3.45M $3.76M $0 -- -- -- -- -- -- --
Gross Profit -$2.08M -$2.93M $0 -- -- -- -- -- -- --
Selling, General & Admin -- $117K $704K -- -- -- -- -- -- --
Total Operating Expenses $1.26M $696K $1.58M $5.21M $2.99M $14.49M $15.98M $954K $6.6K $1.00M
Operating Income -$3.35M -$3.63M -$1.58M -$5.21M -$2.99M -$14.49M -$15.98M -$954K -$6.6K -$1.00M
EBITDA -- -$3.63M -$1.45M -$4.92M -$2.99M -$14.36M -$15.85M -$954K -$6.6K -$1.00M
Interest Expense $1.96M $2.26M $1.69M $2.29M $1.51M $2.29M $4.47M $2.14M $0 $423
Income Before Tax -- -- -- -$8.53M -$8.83M -$19.89M -$20.45M -$3.09M -$6.6K -$1.00M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$11.13M -$9.91M $3.69M -$8.53M -$8.83M -$19.89M -$20.45M -$3.09M -$6.6K -$1.00M
Basic EPS -- -- -- $0.04 $0.12 -$0.49 -$0.66 -$0.17 $0.00 -$0.06
Diluted EPS -$0.02 -$0.02 $0.01 $0.04 $0.12 -$0.49 -$0.66 -$0.17 $0.00 -$0.06
Basic Shares Outstanding -- -- -- 211.0M 74.7M 40.7M -- -- -- --
Diluted Shares Outstanding 662.5M 625.3M 308.9M 211.0M 74.7M 40.7M 31.2M 18.0M 18.0M 18.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $138K $276K $627K $139K $657K $232K $335K $482K
Cost of Revenue $415K $415K $1.04M $856K $1.03M $853K $838K $2.17M
Gross Profit -$278K -$138K -$409K -$717K -$374K -$621K -$503K -$1.69M
Total Operating Expenses $255K $240K $273K $177K $562K $220K $175K -$163K
Operating Income -$533K -$379K -$682K -$894K -$936K -$841K -$678K -$1.53M
EBITDA -- -- -$667K -- -$936K -$841K -$678K --
Interest Expense $458K $349K $476K $179K $506K $658K $616K $322K
Income Before Tax $645K -$1.91M -- -- -$1.48M -$1.41M -- --
Income Tax Expense $0 $0 -- -- $0 $0 -- --
Net Income $645K -$1.91M -$382K -$7.55M -$1.48M -$1.41M -$691K -$3.74M
Basic EPS $0.00 $0.00 -- -- $0.00 $0.00 -- --
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Basic Shares Outstanding 708.7M 682.5M -- -- 662.5M 662.5M 662.5M --
Diluted Shares Outstanding 1.27B 682.5M 669.8M -- 662.5M 662.5M 662.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.8K $2.2K $650 $2.3K $28K $335K $1.5K $464K $0 $0
Cash & Short-Term Investments $1.8K $2.2K $650 $2.3K $28K $335K $1.5K $464K $0 $0
Accounts Receivable, Net $164K $1.7K $0 -- -- -- -- -- -- --
Inventory $1.12M $996K $1.13M -- -- -- -- -- -- --
Other Current Assets -- -- -- $5.9K $0 -- -- -- -- --
Total Current Assets $1.31M $1.02M $1.20M $100K $30K $468K $1.93M $599K $0 $1.7K
Property, Plant & Equipment, Net $127K $137K $162K $108K $6.0K $1.57M $1.54M $1.69M $0 $0
Goodwill -- -- -- -- -- $0 $6.37M $6.07M -- --
Intangible Assets -- -- -- -- -- $0 $1.83M -- -- --
Total Non-Current Assets $5.71M $9.82M $10.55M $5.31M $85K $8.28M $14.09M $9.50M $0 $0
Total Assets $7.02M $10.84M $11.75M $5.41M $114K $8.75M $16.02M $10.10M $0 $1.7K
Accounts Payable $10.06M $4.78M $4.93M $6.88M $3.13M $3.58M $903K $766K $605K --
Short-Term Debt -- -- -- -- -- -- -- $0 -- --
Deferred Revenue (Current) $261K $0 -- -- -- -- -- -- -- --
Other Current Liabilities $2.17M -- -- -- -- -- -- -- -- --
Total Current Liabilities $31.59M $25.75M $18.73M $17.43M $13.04M $17.55M $5.66M $3.75M $964K $959K
Long-Term Debt -- -- -- -- -- -- -- $6.63M -- --
Total Non-Current Liabilities $5.58M $4.89M $5.17M $5.33M $0 $0 $5.50M $6.63M $0 $0
Total Liabilities $37.17M $30.65M $23.90M $22.76M $13.04M $17.55M $11.16M $10.38M $964K $959K
Total Debt (incl. Leases) $6.03M $5.62M -- -- -- -- -- $6.63M -- --
Common Stock $66K $66K $44K $27K $13K $4.7K $3.6K $1.9K $1.8K $1.8K
Retained Earnings -$112.3M -$101.2M -$91.28M -$94.70M -$86.16M -$77.33M -$57.44M -$36.99M -$33.90M -$33.89M
Accumulated Other Comp. Income -$57K $556K -$36K $240K -$372K -$346K $138K $0 -- --
Total Stockholders' Equity -$30.15M -$19.81M -$12.15M $17.34M -$12.93M -$8.80M $4.85M -$286K -$964K -$958K
Total Equity -$30.15M -$19.81M -$12.15M $17.34M -$12.93M -$8.80M $4.85M -$286K -$964K -$958K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $32K $555 $633 $1.8K $927 $17K $1.2K $2.2K
Cash & Short-Term Investments $32K $555 $633 $1.8K $927 $17K $1.2K $2.2K
Accounts Receivable, Net $0 $6.8K $6.9K $164K $588K $114K $263K $1.7K
Inventory $1.70M $1.31M $903K $1.12M $864K $1.04M $951K $996K
Total Current Assets $1.74M $1.33M $930K $1.31M $1.47M $1.20M $1.24M $1.02M
Property, Plant & Equipment, Net $195K $200K $176K $127K $123K $129K $130K $137K
Total Non-Current Assets $5.55M $5.56M $5.65M $5.71M $10.15M $10.27M $10.00M $9.82M
Total Assets $7.29M $6.89M $6.58M $7.02M $11.62M $11.47M $11.23M $10.84M
Accounts Payable $10.69M $10.48M -- $10.06M $5.61M $5.46M $5.07M $4.78M
Deferred Revenue (Current) $36K $36K $0 $261K -- -- $66K $0
Other Current Liabilities $908K -- -- $2.17M -- -- -- --
Total Current Liabilities $32.67M $32.57M $31.49M $31.59M $28.48M $28.95M $26.89M $25.75M
Total Non-Current Liabilities $4.81M $5.15M $5.36M $5.58M $5.65M $5.09M $4.85M $4.89M
Total Liabilities $37.47M $37.72M $36.85M $37.17M $34.13M $34.05M $31.74M $30.65M
Total Debt (incl. Leases) $5.77M $5.78M $5.91M $6.03M -- -- -- $5.62M
Common Stock $71K $71K $68K $66K $66K $66K $66K $66K
Retained Earnings -$114.0M -$114.6M -$112.7M -$112.3M -$104.8M -$103.3M -$101.9M -$101.2M
Accumulated Other Comp. Income $527K $528K $209K -$57K $174K -$105K $549K $556K
Total Stockholders' Equity -$30.19M -$30.83M -$30.27M -$30.15M -$22.52M -$22.57M -$20.51M -$19.81M
Total Equity -$30.19M -$30.83M -$30.27M -$30.15M -$22.52M -$22.57M -$20.51M -$19.81M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.13M -$9.91M $3.69M -$8.53M -$8.83M -$19.89M -$20.45M -$3.09M -$6.6K -$1.00M
Depreciation & Amortization -- $0 $128K $295K $2.7K $129K $129K $0 $0 $0
Stock-Based Compensation -- -- -- $181K $363K $820K $736K $28K $0 $728K
Change in Receivables -$1.01M -$1.7K $0 -$22K -$1.2K $28K $0 -- -- --
Change in Inventory -$1.99M -$508K -$1.13M -- -- -- -- -- -- --
Change in Payables $157K $0 -- -- -- -- -- -- -- --
Operating Cash Flow -$789K -$1.70M -$2.27M -$1.45M -$2.41M -$564K -$3.79M -$941K $0 -$22K
Capital Expenditure -$5.5K $0 -$81K -$116K -$6.3K $0 -$4.8K $0 -- $0
Free Cash Flow -$795K -$1.70M -$2.36M -$1.56M -$2.42M -$564K -$3.80M -$941K -- -$22K
Acquisitions, Net -- -- -- -- -- -- $0 -$727K $0 --
Investing Cash Flow $794K $1.70M -$81K -$116K $494K $0 -$47K -$727K $0 $0
Common Stock Issued -- -- -- $290K $291K $0 -- -- -- $0
Share Repurchases -- -- -- -- -- $0 -$99K $0 -- --
Financing Cash Flow -$5.5K $0 $2.35M $1.40M $1.34M $825K $3.27M $2.13M $0 $20K
Net Change in Cash -$352 $1.5K -$1.7K -$25K -$307K $261K -$575K $464K $0 -$2.6K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $645K -$1.91M -$382K -$7.55M -$1.48M -$1.41M -$691K -$3.74M
Depreciation & Amortization -- -- $16K -- $0 $0 $0 --
Change in Receivables -$2.8K -$269K -$359K -$431K -$479K $160K -$261K $181K
Change in Inventory -$526K -$632K -$281K -$893K -$90K -$589K -$416K $108K
Operating Cash Flow -$167K -$127K -$244K $1.06M -$803K -$446K -$601K -$180K
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$180K
Investing Cash Flow -- -- -- -- -- -- -- $1.70M
Financing Cash Flow $199K $182K $242K -$1.85M $787K $462K $600K -$1.52M
Net Change in Cash $31K -$78 -$1.2K $877 -$16K $16K -$948 -$4.8K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -153.1% -357.9% -- -- -- -- -- -- -- --
Operating Margin -245.8% -442.7% -- -- -- -- -- -- -- --
Net Profit Margin -817.2% -1207.8% -- -- -- -- -- -- -- --
Return on Equity (ROE) -- -- -- -49.2% -- -- -421.3% -- -- --
Return on Assets (ROA) -158.6% -91.4% 31.4% -157.6% -7725.4% -227.4% -127.7% -30.6% -- -60063.0%
Current Ratio 0.04x 0.04x 0.06x 0.01x 0.00x 0.03x 0.34x 0.16x 0.00x 0.00x
Quick Ratio 0.01x 0.00x 0.00x 0.00x 0.00x 0.02x 0.00x 0.12x 0.00x 0.00x
Revenue Growth (YoY) +66.1% -- -- -- -- -- -- -- -- --
Net Income Growth (YoY) -- -368.6% -- -- -- -- -- -- -- --
EPS Growth (YoY) -- -- -- -66.7% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -130.7% -96.4% -128.2% -162.6% -186.9% -232.9% -240.9% -323.8%
Operating Margin -210.8% -170.1% -202.7% -245.8% -233.5% -261.7% -286.8% -408.7%
Net Profit Margin -779.2% -666.2% -654.2% -817.2% -429.3% -415.5% 99.1% -1207.8%
Return on Assets (ROA) -126.2% -164.2% -164.5% -158.6% -63.0% -49.3% 10.0% -91.4%
Current Ratio 0.05x 0.04x 0.03x 0.04x 0.05x 0.04x 0.05x 0.04x
Quick Ratio 0.00x 0.00x 0.00x 0.01x 0.02x 0.01x 0.01x 0.00x
Revenue Growth (YoY) -79.0% +19.3% +87.1% -71.2% +110.3% -- +1197.7% --
Operating Income Growth (YoY) -- -- -- -- -- -- -- -318.4%
Net Income Growth (YoY) -- -- -- -- -884.3% -126.4% -- -149.6%
Source: SEC EDGAR CompanyFacts (CIK 0001081938) · from March 31, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal